{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:55:20Z","timestamp":1793858120647,"version":"4.6.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.neuropharm.2010.10.009","type":"journal-article","created":{"date-parts":[[2010,10,22]],"date-time":"2010-10-22T10:29:48Z","timestamp":1287743388000},"page":"397-404","source":"Crossref","is-referenced-by-count":39,"title":["Increased binding of cortical and hippocampal group II metabotropic glutamate receptors in isolation-reared mice"],"prefix":"10.1016","volume":"60","author":[{"given":"Toshiyuki","family":"Kawasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Ago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Washida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Onoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeyuki","family":"Chaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuro","family":"Nakazato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akemichi","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Takuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2010.10.009_bib1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1471-4159.2002.01128.x","article-title":"Selective reduction by isolation rearing of 5-HT1A receptor-mediated dopamine release in vivo in the frontal cortex of mice","volume":"83","author":"Ago","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1254\/jphs.FP0070325","article-title":"Anxiety-like and exploratory behaviors of isolation-reared mice in the staircase test","volume":"104","author":"Ago","year":"2007","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib3","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.neuropharm.2008.08.026","article-title":"Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression","volume":"55","author":"Ago","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.bbr.2009.04.010","article-title":"Animal models of gene-environment interactions in schizophrenia","volume":"204","author":"Ayhan","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pbb.2007.11.004","article-title":"Differential effect of environment enrichment and social isolation on depressive-like behavior, spontaneous activity and serotonin and norepinephrine concentration in prefrontal cortex and ventral striatum","volume":"89","author":"Brenes","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s002130050072","article-title":"Attenuation of specific PCP-evoked behaviors by the potent mGlu2\/3 receptor agonist, LY379268, and comparison with the atypical antipsychotic, clozapine","volume":"148","author":"Cartmell","year":"2000","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib7","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1046\/j.1471-4159.2000.0751147.x","article-title":"The potent, selective mGlu2\/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat","volume":"75","author":"Cartmell","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1471-4159.2000.0750889.x","article-title":"Regulation of neurotransmitter release by metabotropic glutamate receptors","volume":"75","author":"Cartmell","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.neuropharm.2003.10.009","article-title":"MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity","volume":"46","author":"Chaki","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib10","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.neuroscience.2006.04.048","article-title":"Medial prefrontal cortex volume loss in rats with isolation rearing-induced deficits in prepulse inhibition of acoustic startle","volume":"141","author":"Day-Wilson","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib11","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00213-003-1578-8","article-title":"Hyperactivity to novelty induced by social isolation is not correlated with changes in D2 receptor function and binding in striatum","volume":"171","author":"Del Arco","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.biopsych.2006.05.047","article-title":"A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment","volume":"61","author":"Duman","year":"2007","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1124\/jpet.108.136861","article-title":"Evidence for the role of\u00a0metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2\/3 receptor agonist (\u2212)-(1 R,4 S,5 S,6 S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039)","volume":"326","author":"Fell","year":"2008","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pnpbp.2009.11.018","article-title":"Elevated level of metabotropic glutamate receptor 2\/3 in the prefrontal cortex in major depression","volume":"34","author":"Feyissa","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib15","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.neubiorev.2008.03.003","article-title":"Behavioural and neurochemical effects of post-weaning social isolation in rodents-relevance to developmental neuropsychiatric disorders","volume":"32","author":"Fone","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature06612","article-title":"Identification of a serotonin\/glutamate receptor complex implicated in psychosis","volume":"452","author":"Gonz\u00e1lez-Maeso","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2004.02.015","article-title":"Selective action of (\u2212)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268), a group II metabotropic glutamate receptor agonist, on basal and phencyclidine-induced dopamine release in the nucleus accumbens shell","volume":"47","author":"Greenslade","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib19","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0091-3057(97)00510-8","article-title":"Isolation rearing in rats: pre- and postsynaptic changes in striatal dopaminergic systems","volume":"59","author":"Hall","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib20","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.biopsych.2004.06.009","article-title":"Reduced N-acetylaspartate in the temporal cortex of rats reared in isolation","volume":"56","author":"Harte","year":"2004","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib21","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0306-4522(00)00336-5","article-title":"Behavioral, neurochemical and endocrinological characterization of the early social isolation syndrome","volume":"100","author":"Heidbreder","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-008-1236-2","article-title":"Individual contribution of metabotropic glutamate receptor (mGlu) 2 and 3 to c-Fos expression pattern evoked by mGlu2\/3 antagonism","volume":"201","author":"Hetzenauer","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0091-3057(89)90516-9","article-title":"Effect of isolation on brain monoamines and the behavior of mice in tests of exploration, locomotion, anxiety and behavioral \u2018despair\u2019","volume":"33","author":"Hilakivi","year":"1989","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib24","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1527-3458.2007.00024.x","article-title":"The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268","volume":"13","author":"Imre","year":"2007","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainres.2005.02.032","article-title":"AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist","volume":"1042","author":"Karasawa","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00213-007-0962-1","article-title":"Galantamine and donepezil differently affect isolation rearing-induced deficits of prepulse inhibition in mice","volume":"196","author":"Koda","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib27","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0014-4886(03)00248-6","article-title":"Modification of hippocampal neurogenesis and neuroplasticity by social environments","volume":"183","author":"Lu","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib28","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0028-3908(02)00057-6","article-title":"Imipramine treatment up-regulates the expression and function of mGlu2\/3 metabotropic glutamate receptors in the rat hippocampus","volume":"42","author":"Matrisciano","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib29","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.neuropharm.2008.05.014","article-title":"Defective group-II metaboropic glutamate receptors in the hippocampus of spontaneously depressed rats","volume":"55","author":"Matrisciano","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib30","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1038\/sj.npp.1300507","article-title":"Impoverished rearing environment alters metabotropic glutamate receptor expression and function in the prefrontal cortex","volume":"29","author":"Melendez","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib31","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.281.5381.1349","article-title":"Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats","volume":"281","author":"Moghaddam","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/syn.10167","article-title":"Effect of isolation rearing on pre- and post-synaptic serotonergic function in the rat dorsal hippocampus","volume":"47","author":"Muchimapura","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1126\/science.1329206","article-title":"Molecular diversity of glutamate receptors and implications for brain function","volume":"258","author":"Nakanishi","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1254\/jphs.09024FP","article-title":"Methamphetamine- and 3,4-methylenedioxymethamphetamine-induced behavioral changes in histamine H3-receptor knockout mice","volume":"111","author":"Okuda","year":"2009","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s007260070037","article-title":"The role of glutamate receptors in antipsychotic drug action","volume":"19","author":"Ossowska","year":"2000","journal-title":"Amino Acids"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib36","first-page":"525","article-title":"Chronic imipramine treatment reduces inhibitory properties of group II mGlu receptors without affecting their density or affinity","volume":"59","author":"Pa\u0142ucha","year":"2007","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib37","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nm1632","article-title":"Activation of mGlu2\/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial","volume":"13","author":"Patil","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib38","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.bcp.2007.09.021","article-title":"Mood disorders: regulation by metabotropic glutamate receptors","volume":"75","author":"Pilc","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0028-3908(94)00129-G","article-title":"The metabotropic glutamate receptors: structure and functions","volume":"34","author":"Pin","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib40","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.neuroscience.2003.10.008","article-title":"Region specific changes in forebrain 5-hydroxytryptamine1A and 5-hydroxytryptamine2A receptors in isolation-reared rats: an in vitro autoradiography study","volume":"123","author":"Preece","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-007-0758-3","article-title":"In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2\/3 receptor agonist LY404039 in animal models of psychiatric disorders","volume":"193","author":"Rorick-Kehn","year":"2007","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-2999(01)01511-4","article-title":"Involvement of benzodiazepine binding sites in an antiaggressive effect by 5-HT1A receptor activation in isolated mice","volume":"432","author":"Sakaue","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib43","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders","volume":"7","author":"Sanacora","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neuroscience.2008.12.019","article-title":"Effects of social isolation rearing on the limbic brain: a combined behavioral and magnetic resonance imaging volumetry study in rats","volume":"159","author":"Schubert","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib45","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0006-8993(03)03042-7","article-title":"Decreased dendritic spine density on prefrontal cortical and hippocampal pyramidal neurons in postweaning social isolation rats","volume":"983","author":"Silva-G\u00f3mez","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib46","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0024-3205(03)00509-5","article-title":"Antipsychotic action of selective group II metabotropic glutamate receptor agonist MGS0008 and MGS0028 on conditioned avoidance responses in the rat","volume":"73","author":"Takamori","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib47","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.neuroscience.2009.10.039","article-title":"The effects of sub-chronic clozapine and haloperidol administration on isolation rearing induced changes in frontal cortical N-methyl-d-aspartate and D1 receptor binding in rats","volume":"165","author":"Toua","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib48","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/syn.20665","article-title":"Increased expression of the NR2A NMDA receptor subunit in the prefrontal cortex of rats reared in isolation","volume":"63","author":"Turnock-Jones","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib49","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s002130100800","article-title":"Environmental animal models for sensorimotor gating deficiencies in schizophrenia: a review","volume":"156","author":"Weiss","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib50","first-page":"844","article-title":"Olfactory bulbectomy and amitriptyline treatment influences mGlu receptors expression in the mouse brain hippocampus","volume":"60","author":"Wiero\u0144ska","year":"2008","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/187152707780363302","article-title":"Metabotropic glutamate receptors in the control of mood disorders","volume":"6","author":"Witkin","year":"2007","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib52","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0022-3565(24)29402-7","article-title":"[3H]LY341495 binding to group II metabotropic glutamate receptors in rat brain","volume":"298","author":"Wright","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib53","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1016\/j.bmc.2006.01.060","article-title":"Prodrugs of 3-(3,4-dichlorobenzyloxy)-2-amino-6- fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (MGS0039): a potent and orally active group II mGluR antagonist with antidepressant-like potential","volume":"14","author":"Yasuhara","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.neuropharm.2010.10.009_bib54","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00213-006-0390-7","article-title":"An mGluR2\/3 antagonist, MGS0039, exerts antidepressant and anxiolytic effects in behavioral models in rats","volume":"186","author":"Yoshimizu","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.009_bib55","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.pnpbp.2009.06.016","article-title":"Isolation rearing induces social and emotional function abnormalities and alters glutamate and neurodevelopment-related gene expression in rats","volume":"33","author":"Zhao","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatr."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390810002790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390810002790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T01:36:49Z","timestamp":1740620209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390810002790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":55,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0028390810002790"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2010.10.009","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}